Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Tan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Annals of the Academy of Medicine, Singapore|January 18, 2005
The impact of microanastomosis of the intramuscular nerve branch on the healing of a completely lacerated skeletal muscle: a histopathological analysisL Zheng, J A C Tan, B L Tan, et al.
Human Mutation|September 5, 2018
Insights into the genotype-phenotype correlation and molecular function of SLC25A46Alexander J Abrams, Flavia Fontanesi, Natalie B L Tan, et al.
NPJ Biofilms and Microbiomes|August 12, 2023
Social demographics determinants for resistome and microbiome variation of a multiethnic community in Southern MalaysiaJ Dwiyanto, M A L Huët, M H Hussain, et al.
Investigational New Drugs|December 21, 2018
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteersLisa Seitz, Lixia Jin, Manmohan Leleti, et al.
Clinical Pharmacology in Drug Development|January 19, 2026
A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy VolunteersVipul K Gupta, Brian Yoo, Daniel Weiss, et al.
Singapore Medical Journal|August 3, 2011
Ministry of Health clinical practice guidelines: schizophreniaS Verma, L L Chan, K S Chee, et al.
Molecular Cancer Therapeutics|April 11, 2022
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor ImmunityDana Piovesan, Joanne B L Tan, Annette Becker, et al.
Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
Singapore Medical Journal|February 17, 2012
Ministry of Health clinical practice guidelines: depressionH C Chua, L L Chan, K S Chee, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Annals of the Academy of Medicine, Singapore|January 18, 2005
The impact of microanastomosis of the intramuscular nerve branch on the healing of a completely lacerated skeletal muscle: a histopathological analysisL Zheng, J A C Tan, B L Tan, et al.
Human Mutation|September 5, 2018
Insights into the genotype-phenotype correlation and molecular function of SLC25A46Alexander J Abrams, Flavia Fontanesi, Natalie B L Tan, et al.
NPJ Biofilms and Microbiomes|August 12, 2023
Social demographics determinants for resistome and microbiome variation of a multiethnic community in Southern MalaysiaJ Dwiyanto, M A L Huët, M H Hussain, et al.
Investigational New Drugs|December 21, 2018
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteersLisa Seitz, Lixia Jin, Manmohan Leleti, et al.
Clinical Pharmacology in Drug Development|January 19, 2026
A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy VolunteersVipul K Gupta, Brian Yoo, Daniel Weiss, et al.
Singapore Medical Journal|August 3, 2011
Ministry of Health clinical practice guidelines: schizophreniaS Verma, L L Chan, K S Chee, et al.
Molecular Cancer Therapeutics|April 11, 2022
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor ImmunityDana Piovesan, Joanne B L Tan, Annette Becker, et al.
Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
Singapore Medical Journal|February 17, 2012
Ministry of Health clinical practice guidelines: depressionH C Chua, L L Chan, K S Chee, et al.
Pageof 3